🧬 Moonshot AI to steer Kimi from code to science

At Web Summit in Lisbon, Moonshot AI announced the transition of its Kimi models from coding to biology, chemistry, and pharma. International Director Giacomo Ficari explained that science requires stronger models, while demand for code is saturating. Kimi K3.1 Pro is operating within DP Technology's BioMaster agent: analyzing 3,696 mouse cells took 90 minutes instead of 4–8 hours, and 100 candidate genes were identified.

🌍 This intensifies competition with OpenAI and Anthropic for the scientific agent niche; biological data is becoming a new benchmark for frontier models. The pharma sector remains cautious: according to a Citi survey, 72% of R&D leaders are using AI, but only 24% expect an increase in drug development success rates.

👤 This represents an acceleration of routine analysis and a vendor case study without independent scientific verification; details are available at kimi.com and via the API.

Source 1: https://the-decoder.com/moonshot-ai-pivots-kimi-models-from-coding-to-science-as-benchmark-gains-flatten/ Source 2: https://www.kimi.com/customers/dp-technology